Kakhniashvili T, Tabagari-Bregvadze N, Dzvelaia Sh, Chikadze A, Kurashvili R
Davit Tvildiani Medical University; Diabetes, Endocrine and Cardio-pulmonary Disease Center "Diacor"; P. Sarajishvili Institute of Neurolog, Tbilisi, Georgia.
Georgian Med News. 2018 Oct(283):55-58.
Our aim was to compare serum vascular endothelial growth factor (VEGF) level in type 2 diabetes mellitus (T2DM) patients with comorbid OSA at screening and 6 month follow up visits. In the prospective cohort study following data were collected at screening visit: medical anamnesis; demographic and anthropometric data; Epworth sleepiness score data; laboratory (serum VEGF, complete blood count, biochemistry, immunology, complete urine test, including microalbuminuria) and instrumental investigation data (fundoscophy, laboratory polysomnography). At 6 months follow up visit we evaluated anthropometric data; Epworth sleepiness score; serum VEGF. Comparing VEGF level at screening and 6 month follow up visits showed significant decrease in VEGF level in both groups (P=0.0281 OSA+ and P=0.0278 OSA-). It was established direct correlation between decreased VEGF level and decreased HbA1c level (P=0.04696) and between decreased VEGF level and Epworth sleepiness score (P=0.0153) at 6 month follow up visit in OSA+ group. Our the study suggests that VEGF level decreases in parallel with diabetes compensation quality. Future researches are necessary to support this research.
我们的目的是比较2型糖尿病(T2DM)合并阻塞性睡眠呼吸暂停(OSA)患者在筛查时及随访6个月时的血清血管内皮生长因子(VEGF)水平。在前瞻性队列研究中,在筛查访视时收集了以下数据:病史;人口统计学和人体测量数据;爱泼华嗜睡量表评分数据;实验室检查(血清VEGF、全血细胞计数、生化、免疫、尿常规,包括微量白蛋白尿)和器械检查数据(眼底检查、实验室多导睡眠图)。在随访6个月时,我们评估了人体测量数据;爱泼华嗜睡量表评分;血清VEGF。比较筛查时和随访6个月时的VEGF水平,两组的VEGF水平均显著降低(OSA+组P=0.0281,OSA-组P=0.0278)。在OSA+组随访6个月时,发现VEGF水平降低与糖化血红蛋白(HbA1c)水平降低之间存在直接相关性(P=0.04696),且VEGF水平降低与爱泼华嗜睡量表评分之间也存在直接相关性(P=0.0153)。我们的研究表明,VEGF水平与糖尿病控制质量呈平行下降。未来需要进一步的研究来支持这项研究。